Key result
Pancreatic cancer cachexia blunts cardiac contractile reserve via β1-adrenergic receptor desensitization under stress.
Why the study?
Cancer cachexia in pancreatic ductal adenocarcinoma causes muscle wasting and activates the sympathetic nervous system, but its impact on cardiac adrenergic signalling remains poorly understood.
Pancreatic cancer cachexia promotes cardiac dysfunction through increased sympathetic drive and β1-adrenergic receptor desensitization, reducing contractile reserve under stress.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for reduced cardiac reserve in cachectic patients; leaves open relevance to human pancreatic cancer.
Cancer cachexia is a metabolic syndrome commonly observed in patients with pancreatic ductal adenocarcinoma (PDAC), characterized by wasting of skeletal and cardiac muscle. This condition is associated with the neurohormonal stress response and activation of the sympathetic nervous system. However the impact of cachexia on cardiac adrenergic signalling remains poorly understood. Here we used a preclinical model of PDAC cachexia to investigate how sympathetic input to the heart is altered. We found desensitization of β1-adrenergic receptor (β1-AR) in the heart, along with evidence of increased adrenergic tone. Pharmacological blockade with the β1-selective antagonist metoprolol partially restored adrenergic responsiveness in PDAC mice, suggesting that elevated adrenergic drive contributes to β1-AR desensitization. The impaired β1-AR sensitivity blunted the chronotropic response to dobutamine and reduced inotropic reserve under adrenergic stress. Together these findings uncover disruption of cardiac adrenergic signalling in PDAC cachexia. KEY POINTS: Pancreatic cancer-associated cachexia promotes β1-adrenergic receptor desensitization in the heart. Pancreatic cancer-induced β1-adrenergic receptor desensitization is partly mediated by increased adrenergic transmission to the heart. β1-adrenergic receptor desensitization in mice with pancreatic cancer reduces contractile reserve under adrenergic stress.
No takes yet. Share an insight, caveat, or question.
Diba et al. (2026) studied Pancreatic ductal adenocarcinoma (PDAC) cachexia. Pancreatic ductal adenocarcinoma (PDAC) cachexia model vs. Sham-operated controls was evaluated on Cardiac β1-adrenergic receptor (β1-AR) expression and desensitization. Pancreatic cancer-associated cachexia promotes β1-adrenergic receptor desensitization in the heart, which reduces contractile reserve under adrenergic stress.
Synapse has enriched 10 related papers. Consider them for comparative context: